Sudarshan Chemical Industries Limited – Corporate Update (12 November 2025)
Board‑Level Decisions
On 12 November 2025, the Board of Sudarshan Chemical Industries Limited (SUDARSCHEM) approved the following actions:
| Item | Decision | Details |
|---|---|---|
| Investment in Subsidiary | Approved under Regulation 30 | Equity capital investment in Sudarshan Europe B.V., a wholly‑owned subsidiary. The approval is documented on the BSE website. |
| Directorate Change | Approved under Regulation 30 | A change in the board of directors has been disclosed. Specific details of the appointment are not disclosed in the press release. |
| Board Meeting Outcome | Outcome released | The minutes of the meeting were published on the BSE portal, confirming the above decisions and indicating that no other material business was transacted. |
Financial Performance – Quarter and Half‑Year 30 September 2025
An unaudited report for the quarter ending 30 September 2025 and the first half of FY 25‑26 was released on 12 November 2025. Key highlights from the report (as presented on the BSE portal) are:
- Revenue: The company reported consolidated revenue for the quarter, showing growth relative to the same period in the previous year.
- Profitability: Consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) and net profit figures were posted, though the exact amounts were not disclosed in the brief.
- Segment Performance: The two operating segments – Pigments and Others – were summarized, with the Pigments segment continuing to drive the majority of sales.
- Cash Position: Cash and cash equivalents were reported, indicating liquidity for upcoming capital expenditure plans.
The unaudited nature of the data suggests that the figures are preliminary and subject to verification in the forthcoming audited accounts.
Analyst Engagement
Two separate notifications were issued on 11 November 2025 concerning analyst engagement:
- Analyst Meet Intimation – A formal notice indicating that an analyst meeting had been scheduled.
- Analysts/Institutional Investor Meet/Conference Call Updates – An update on the call, though the specific agenda items or outcomes were not detailed.
Both notifications were posted on the BSE and NSE websites and confirm the company’s intent to provide further insight into its financial results and strategic direction.
Market Context
- Share Price (10 November 2025): ₹1,051.60
- 52‑Week Range: ₹796.15 – ₹1,603.00
- Market Capitalisation: ₹89,442,959,360
- P/E Ratio: 108.03
These metrics provide a snapshot of the company’s valuation and share‑price performance, positioning the firm within the broader materials and chemicals sector in India.
